Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
3,900
Employees3,900
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
3,900
Employees3,900

PODD Key Statistics

Market cap
23.03B
Market cap23.03B
Price-Earnings ratio
98.06
Price-Earnings ratio98.06
Dividend yield
Dividend yield
Average volume
627.56K
Average volume627.56K
High today
$328.35
High today$328.35
Low today
$319.13
Low today$319.13
Open price
$322.03
Open price$322.03
Volume
110.49K
Volume110.49K
52 Week high
$353.50
52 Week high$353.50
52 Week low
$225.37
52 Week low$225.37

PODD News

Simply Wall St 21h
Will Insulet’s New CFO Shape a Stronger Growth Path Amid Rising Revenue Guidance?

Insulet Corporation has announced that Flavia Pease, a highly experienced executive in global healthcare and medical technology, succeeded Ana Maria Chadwick as...

Will Insulet’s New CFO Shape a Stronger Growth Path Amid Rising Revenue Guidance?
Reuters 2d
Medical device maker Insulet taps industry veteran Flavia Pease as CFO - Reuters

...

Medical device maker Insulet taps industry veteran Flavia Pease as CFO - Reuters
TipRanks 2d
Insulet Appoints New CFO Amid Revenue Growth

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

82%

of 28 ratings
Buy
82.1%
Hold
17.9%
Sell
0%

More PODD News

TipRanks 2d
Insulet expects to exceed Q3 revenue view of up 22%-25%

The company said, “Insulet (PODD) expects to exceed its previously issued third quarter 2025 total revenue growth guidance, driven by strong new customer starts...

Seeking Alpha 2d
Insulet taps new CFO; expects to top Q3 revenue growth outlook

Healthcare Insulet taps new CFO; expects to top Q3 revenue growth outlook Sep. 16, 2025 7:11 AM ET Insulet Corporation (PODD) Stock By: Preeti Singh, SA News Ed...

Insulet taps new CFO; expects to top Q3 revenue growth outlook
TipRanks 2d
Insulet CFO Ana Maria Chadwick to leave role, Flavia Pease to succeed

Insulet (PODD) announced that Flavia Pease will succeed Ana Maria Chadwick as executive VP, CFO, effective September 30. Chadwick will become a senior advisor t...

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.